Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Considering Staff Of 30-35 People – Executive Director Selby

Executive Summary

With the Patient-Centered Outcomes Research Institute’s executive director, Joe Selby, officially on the job, attention now is on building the institute’s permanent staff.

You may also be interested in...



Physicians Still Concerned PCORI Will Investigate Cost-Effectiveness

Despite a carefully worded statute aimed at keeping cost-effectiveness research out of the work conducted by the Patient-Centered Outcomes Research Institute, the American Medical Association is still concerned that cost could play a role in the institute’s work.

Physicians Still Concerned PCORI Will Investigate Cost-Effectiveness

Despite a carefully worded statute aimed at keeping cost-effectiveness research out of the work conducted by the Patient-Centered Outcomes Research Institute, the American Medical Association is still concerned that cost could play a role in the institute’s work.

PCORI To Seek Input On Areas Of Interest For Tier 1 Research Grants

The Patient-Centered Outcomes Research Institute’s Program Development Committee is eyeing Aug. 1 as the date it will begin the process for soliciting proposals for its “Tier 1” research grants.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS053654

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel